Zostavax

Merck's Promising Vaccine Empire

Merck's Promising Vaccine Empire

Seeking Alpha

Merck's New Vaccine, Partnerships Will Drive Stock Higher

Merck's New Vaccine, Partnerships Will Drive Stock Higher

Seeking Alpha

With Zostavax supplies restored, Merck aims for revival

With Zostavax supplies restored, Merck aims for revival

Fierce Pharma

Ample Supplies of Shingles Vaccine Return

Ample Supplies of Shingles Vaccine Return

WSJ

Merck: High Upside Expected From Vaccine

Merck: High Upside Expected From Vaccine

Seeking Alpha

ADDING and REPLACING FDA Expands Indication for ZOSTAVAX®, Merck’s Shingles Vaccine, to Include Adults Ages 50 to 59

ADDING and REPLACING FDA Expands Indication for ZOSTAVAX®, Merck’s Shingles Vaccine, to Include Adults Ages 50 to 59

Yahoo/BusinessWire

FDA OKs shingle vaccine for those aged 50 to 59

FDA OKs shingle vaccine for those aged 50 to 59

Reuters

News

Merck Vaccine Cuts Risk of Shingles by Half, Researchers Find

Bloomberg